AKTX vs IDXX · $17.2M cap vs P/E 40, rev $2.36B
Akari Therapeutics PLC (AKTX) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
AKTX does not have a complete income-statement cache yet.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
AKTX currently screens at market cap $17.2M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the AKTX and IDXX stock pages for the full models.
Not investment advice.